While 2022 was a near-record year for private equity healthcare dealmaking and VC fundraising, the S&P 500 dropped nearly 20% last year. Funding for early-stage companies as well as digital health appears to have cooled. With economists predicting a recession, Fierce Healthcare spoke with investors and advisers about what capital markets currently look like for healthcare and where they’re headed. “2022 was a year of tremendous pressure on the healthcare industry,” Duane Fitch, national healthcare management consulting leader at Plante Moran, told Fierce Healthcare, with “pretty much every dynamic going in the wrong direction.” Read more.
How the Current Economic Downturn Impacts Healthcare Funding and Investor Strategy
